In non-cancerous cells, TGFβ impedes tumor formation; however, in tumor cells, TGFβ enhances tumorigenesis by enabling epithelial to mesenchymal transition (EMT), dampening immune surveillance and promoting angiogenesis (Batlle and Massagué, 2019). The gene discussed is TGFB1; the disease is neoplasm.